Help | Scores |Exit
Fragmin | Magnex | Solu Medrol
Clopamide Drug Name:  
A|B|C|D|E|F|G|H|I|K|L|M|N|O|P|Q|R|S|T|V|Z
Indications
Dosages
Interactions
Precautions
Contraindications
Adverse Reactions
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Interactions:

Benazepril

  • Adverse Effect: postural hypotension (first dose)  
  • Clinical Management: Start with a very low dose of Benazepril in the evening and closely monitor blood pressure for a severe hypotensive response for four hours after the initial dose. Monitor for hypotension, fluid status, and body weight regularly for up to two weeks after dose adjustments.

    Captopril

  • Adverse Effect: postural hypotension (first dose)  
  • Clinical Management: Start with a very low dose of Clopamide in the evening and closely monitor blood pressure for a severe hypotensive response for four hours after the initial dose. Monitor for hypotension, fluid status, and body weight regularly for up to two weeks after dose adjustments.

    Captopril Comb.

  • Adverse Effect: Postural hypotension (first dose)  
  • Clinical Management: Start with a very low dose of Comb. Captopril in the evening and closely monitor blood pressure for a severe hypotensive response for four hours after the initial dose. Monitor for hypotension, fluid status, and body weight regularly for up to two weeks after dose adjustments.

    Celecoxib

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Digoxin

  • Adverse Effect: Digoxin toxicity (nausea, vomiting, arrhythmias)  
  • Clinical Management: Patients given Clopamide with Digoxin should be told to add rich sources of potassium to their diet or they should be given potassium supplements, even though their serum potassium level is normal. The use of combination potassium-sparing potassium-depleting diuretics is also a rational approach. You may want to include some extra potassium in your diet.

    Enalapril

  • Adverse Effect: postural hypotension (first dose)  
  • Clinical Management: Start with a very low dose of Enalapril in the evening and closely monitor blood pressure for a severe hypotensive response for four hours after the initial dose. Monitor for hypotension, fluid status, and body weight regularly for up to two weeks after dose adjustments.

    Enalapril Comb.

  • Adverse Effect: Postural hypotension (first dose)  
  • Clinical Management: Start with a very low dose of Comb. Enalapril in the evening and closely monitor blood pressure for a severe hypotensive response for four hours after the initial dose. Monitor for hypotension, fluid status, and body weight regularly for up to two weeks after dose adjustments.

    Flurbiprofen

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Ibuprofen

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Ibuprofen Comb.

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Indomethacin

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Ketoprofen

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Ketorolac

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Lisinopril

  • Adverse Effect: postural hypotension (first dose)  
  • Clinical Management: Start with a very low dose of Lisinopril in the evening and closely monitor blood pressure for a severe hypotensive response for four hours after the initial dose. Monitor for hypotension, fluid status, and body weight regularly for up to two weeks after dose adjustments.

    Lithium

  • Adverse Effect: increased lithium concentrations and lithium toxicity (weakness, tremor, excessive thirst, confusion)  
  • Clinical Management: Monitor serum lithium levels within the first five to seven days of adding or discontinuing Clopamide and periodically thereafter. Lower lithium doses may be required with concomitant Clopamide therapy.

    Mefenamic Acid

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Meloxicam

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Nabumetone

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Naproxen

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Nimesulide

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Oxyphenbutazone

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Paracetamol

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Paracetamol Comb.

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Perindopril

  • Adverse Effect: postural hypotension (first dose)  
  • Clinical Management: Start with a very low dose of Perindopril in the evening and closely monitor blood pressure for a severe hypotensive response for four hours after the initial dose. Monitor for hypotension, fluid status, and body weight regularly for up to two weeks after dose adjustments.

    Phenacetin

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Phenylbutazone

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Piroxicam

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.

    Ramipril

  • Adverse Effect: postural hypotension (first dose)  
  • Clinical Management: Start with a very low dose of Ramipril in the evening and closely monitor blood pressure for a severe hypotensive response for four hours after the initial dose. Monitor for hypotension, fluid status, and body weight regularly for up to two weeks after dose adjustments.

    Ramipril Comb.

  • Adverse Effect: Postural hypotension (first dose)  
  • Clinical Management: Start with a very low dose of Comb. Ramipril in the evening and closely monitor blood pressure for a severe hypotensive response for four hours after the initial dose. Monitor for hypotension, fluid status, and body weight regularly for up to two weeks after dose adjustments.

    Tenoxicam

  • Adverse Effect: Decreased diuretic and antihypertensive efficacy  
  • Clinical Management: When administering thiazide diuretics and nonsteroidal antiinflammatory agents (NSAIDs) concurrently, monitor blood pressure and weight. Also, follow the patient for decreases in urine output and increased edema.
  • Calcium Salts
    Captopril
    Carbamazepine
    CastorOil
    Cefaclor
    Cefadroxil
    CefazolinSodium
    Cefdinir
    CefepimeHydrochloride
    Cefixime
    CefotaximeSodium
    CeftriaxoneSodium
    CefuroximeAxetil
    Cephalexin Hydrochloride Monohydrate
    CetirizineHydrochloride
    Chloral Hydrate
    Chloramphenicol
    Chlordiazepoxide
    Chloroquine Hydrochloride
    Chlorpheniramine Maleate
    Chlorpromazine Hydrochloride
    Chlorthalidone
    Cholestyramine
    Cimetidine
    Ciprofloxacin
    Ciprofloxacin Hydrochloride
    Cisplatin
    Clarithromycin
    ChemastineFumarate
    Clindamycin Hydrochloride
    Clonazepam
    Clotrimazole
    CloxacillinSodium
    CodeinePhosphate
    CortisoneAcetate
    Co-trimoxazole
    CromolynSodium
    Cyanocobalamin
    Cycloserine
    Cyclosporine
    Chlormezanone
    Chlorpropamide
    Clostebol
    Clotrimazole - Topical
    Clotrimazole - VU
    Clozapine
    Coal Tar
    Colchicine
    Colistin Sulphate
    Colloidal Bismuth
    Conj Estrogen
    Corticotrophin
    Cotrimoxazole
    Crotamiton
    Cyclandelate
    Cyclopentolate
    Cyclophosphamide
    Cyproheptadine
    Cytarabine
    Calcipotriol
    Calcitonin
    Calcium Dobesilate
    Candesartan
    Capreomycin
    Carbenicillin
    Carbidopa
    Carbimazole
    Carboplatin
    Carboprost
    Cardioplegia
    Carisoprodol
    Carvedilol
    Catalin
    Cefoperazone
    Cefpirome
    Cefpodoxime
    Ceftazidime
    Ceftibuten
    Ceftizoxime
    Cefuroxime
    Celecoxib
    Celiprolol
    Centchroman
    Cephaloridine
    Cetrimide
    Chenodeoxycholic acid
    Chlorambucil
    Chlorhexidine Gluconate
    Chloroxylenol
    Chlorzoxazone
    Cholera Vaccine
    Ciclopiroxolamine
    Ciclopiroxolamine - VU
    Cinnarizine
    Cisapride
    Citalopram
    Clemastine
    Clidinium Br
    Clidinium Br - Antispas
    Clobazam
    Clobetasol
    Clofazimine
    Clomiphene
    Clomipramine
    Clonidine
    Clopamide
    Clopidogrel
     
    Disclaimer